Wedbush ups SpringWorks target to $81, expects Merck KGaA ‘official’ offer soon
Wedbush raised the firm’s price target on SpringWorks Therapeutics (SWTX) to $81 from $77 and keeps an Outperform rating on the shares ...
Reuters3mon
Merck KGaA
The CEO of Germany's Merck KGaA on Thursday said a recovery in sales growth at its existing business means it can take a cautious approach to buying other companies, which are expensively priced.
Goldman Sachs Sticks to Their Buy Rating for Merck KGaA (0O14)
Goldman Sachs analyst James Quigley maintained a Buy rating on Merck KGaA (0O14 – Research Report) today and set a price target of €185.00. The ...